| Merck Launches Trial Network for Cancer-Drug Creation Merck announced the launch of a global clinical trial network focusing on the development of cancer drugs and vaccines. online.wsj.com |
Spherix Expands Development Strategy for D-Tagatose (PR Newswire) Spherix Incorporated , an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes. Â Reduction of triglyceride levels is a secondary endpoint of the Phase 3 trial. Â Results from the trial are expected later this summer. us.rd.yahoo.com |
Alliance HealthCare Services Announces Completion of Exchange Offer of Its 8.00% Senior Notes for Registered Notes (Business Wire) NEWPORT BEACH, Calif.----Alliance HealthCare Services, Inc. , a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced today that it has completed its offer to exchange up to $190 million aggregate principal amount of its 8.00% series B senior notes due 2016 which have been registered under the Securities Act of 1933, as amended, for any and all of its outstanding 8.00% senior notes due 2016 which were issued in a private placement . us.rd.yahoo.com |
RadNet Enters the Radiology Software Business: Acquires eRAD, Inc. and Assembles an Industry-Leading Radiology Software Team [GlobeNewswire] - LOS ANGELES -- RadNet, Inc. , a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 191 fully-owned and operated outpatient imaging centers, today reported it has executed a definitive agreement to acquire Image Medical Corporation, the parent of eRAD, Inc., for $10.75 million in a combination of cash and promissory notes. us.rd.yahoo.com |
JNJ Recalls More Children's Medicine J&J recalled more children's Benadryl and Motrin after identifying additional manufacturing problems, but said the problems don't threaten the safety of consumers. online.wsj.com |